Itay & Beyond
Patient-derived lab grown brain tissue on a chip, to develop novel treatments for neurology and psyc
Company Overview
Snapshot
Founded in January 2021 by Nissim Perets, Itay & Beyond operates with 11–50 employees. The company is currently in the Pre-Funding stage, focusing on developing patient-derived lab-grown brain tissue on a chip to advance treatments for neurological and psychiatric disorders. In February 2025, the company was featured for its use of AI analysis with brain-on-a-chip technology to predict drug efficacy for neuropsychiatric disorders.
Business overview
Itay & Beyond is a biotech startup specializing in neuropsychiatric drug discovery. The company leverages a platform that utilizes patient-derived lab-grown brain tissue on a chip to develop novel treatments for neurology and psychiatry. Its core technology involves AI analysis of these 'brain-on-a-chip' models to predict drug efficacy, aiming to expedite testing and development in the pharmaceutical and biotechnology sectors, ultimately serving patients in the healthcare and life sciences industries.
Strategic signal
In February 2025, Itay & Beyond was highlighted for its innovative approach to drug discovery, utilizing AI analysis of a 'brain-on-a-chip' made from stem cells. This development is significant as it offers a novel method to predict drug efficacy for neuropsychiatric disorders, potentially accelerating the development of much-needed treatments and signaling a shift towards more efficient and targeted therapeutic research in the biotech industry.
Company Intelligence Q&A
- What is Itay & Beyond's primary focus?
- Itay & Beyond focuses on revolutionizing neuropsychiatric drug discovery through its platform, which uses patient-derived lab-grown brain tissue on a chip to develop novel treatments for neurological and psychiatric conditions.
- When was Itay & Beyond founded?
- Itay & Beyond was founded in January 2021.
- Who is a co-founder of Itay & Beyond?
- Nissim Perets is a co-founder and CEO of Itay & Beyond.
- What innovative technology did Itay & Beyond feature in February 2025?
- In February 2025, Itay & Beyond was featured for its use of AI analysis of a 'brain-on-a-chip' made from stem cells to predict drug efficacy for neuropsychiatric disorders, aiming to expedite testing and development.
- What was reported about Itay & Beyond in January 2025?
- In January 2025, Itay & Beyond was noted for its brain chip innovation, which aims to address autism and epilepsy through next-generation medicine.